人造血管肺动脉重建术治疗中央型肺癌  

Pulmonary artery reconstruction by artificial blood vessel to treat central lung carcinoma

作　　者：尹小川[1] 洪志鹏[1] 太祥[1] 熊国盛[1] 赵炜[1] 

机构地区：[1]昆明医学院第一附属医院胸外科,昆明650032

出　　处：《中华肺部疾病杂志（电子版）》2011年第5期38-39,42,共3页Chinese Journal of Lung Diseases(Electronic Edition)

基　　金：云南省科技计划项目联合专项基金(2010CD160)

摘　　要：目的探讨人造血管在肺动脉重建术对中心型肺癌的治疗效果。方法用人造血管肺动脉成形术或同时行支气管成形术治疗中心型肺癌29例,其中鳞癌20例,腺癌9例;左上叶袖状切除16例,右上叶6例,右中上叶7例。结果本组无手术死亡,术后1例发生支气管胸膜瘘,余28例无并发症,术后1年及3年生存率分别为69%和36%,术后定期彩超检查均未发现重建血管内有血栓形成及血流受阻情况。结论人造血管肺动脉重建术的应用最大限度地切除了肿瘤组织,并最大限度地保留了肺功能,重建肺动脉能长期、有效的维持肺循环功能。Objective To approach therapeutic efficacy of pulmonary artery reconstruction by artificial blood vessel to treat central lung carcinoma. Methods 29 cases of central lung carcinoma, including 20 cases squamous carcinoma and 9 cases adenocarcinoma, were performered pulmonary artery reconstruction by artificial blood vessel operations. There are 16 cases left upper lobe sleeve excision, 6 cases right upper lobe excision and 7 cases right upper plus middle lobe excision. Results There was no operative death in this group. Only one case got the bronchopleural fistula and the other 28 cases got no complications. The survival rate for 1-year and 3-years was 69% and 36%. Inspected by transonic examation, there was no thrombogenesis and blood current obstruction in the reconstructed pulmonary artery. Conclusion Pulmonary artery reconstruction by artificial blood vessel to treat central lung carcinoma can not only maximatily resect tumor but also maximatily reserve pulmonary function. The resconstructed pulmonary artery can sustain pulmonary circulation in a effective long-term.

关 键 词：中心型肺癌 人造血管 肺动脉重建 

分 类 号：R654.3[医药卫生—外科学]